Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - TOTAL ASSETS
Total Assets RARE - Ultragenyx Pharmaceutical Inc.
1.49 B
LAST VALUE
-1.04%
2 YEAR CAGR
15.69%
5 YEAR CAGR
37.97%
10 YEAR CAGR